A seventeen-year prospective cohort study on association of hepatitis B virus e antigen with the risk of hepatocellular carcinoma

Tumor

Volumn 31, Issue 9, 2011, Pages 841-845

  Sun, Yan ^a   Chen, Tao Yang ^a   Lu, Pei Xin ^a   Wang, Jin Bing ^a   Wu, Yan ^a   Zhang, Qi Nan ^a   Jin, Yan ^b   Qian, Geng Sun ^b   Tu, Hong ^b  

^a QIDONG LIVER CANCER INSTITUTE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Hepatitis B e antigens; Liver neoplasms; Prospective studies; Risk assessment

Indexed keywords

HEPATITIS B(E) ANTIGEN;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; PREDICTOR VARIABLE; PROSPECTIVE STUDY;

EID: 80053229217     PISSN: 10007431     EISSN: None     Source Type: Journal    
DOI: 10.3781/j.issn.1000-7431.2011.09.012     Document Type: Article

References (21)

1. BAI X, ZHU Y, JIN Y, et al. Temporal acquisition of sequential mutations in the enhancer II and basal core promoter of HBV in individuals at high-risk for hepatocellular carcinoma[J]. Carcinogenesis, 2011, 32 (1): 63-68.
2. WANG X Y, ZHANG X X, YAO X, et al. Serum HBeAg sero-conversion correlated with decrease of HBsAg and HBV DNA in chronic hepatitis B patients treated with a therapeutic vaccine[J]. Vaccine, 2010, 28 (51): 8169-8174.
3. LIAW Y F, LAU G K, KAO J H, et al. Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection[J]. Dig Dis Sci, 2010, 55 (10): 2727-2734.
4. YU M W, YEH S H, CHEN P J, et al. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men[J]. J Natl Cancer Inst, 2005, 97 (4): 265-272.
5. CHU C M, LIAW Y F, SHEEN I S, et al. Sex difference in chronic hepatitis B virus infection: an appraisal based on the status of hepatitis B e antigen and antibody[J]. Hepatology, 1983, 3 (6): 947-950.
6. TSAI J F, JENG J E, HO M S, et al. Additive effect modification of hepatitis B surface antigen and e antigen on the development of hepatocellular carcinoma[J]. Br J Cancer, 1996, 73 (12): 1498-1502.
7. YANG H I, LU S N, LIAW Y F, et al. HepatitisB e antigen and the risk of hepatocellular carcinoma[J]. N Engl J Med, 2002, 347 (3): 168-174.
8. CHEN C H, LEE C M, LU S N, et al. Clinical significance of hepatitis B virus (HBV) genotypes and precore and core promoter mutations affecting HBV e antigen expression in Taiwan[J]. J Clin Microbiol, 2005, 43 (12): 6000-6006.
9. YANG H I, YEH S H, CHEN P J, et al. Association between hepatitis B genotype and mutations and the risk of hepatocellular carcinoma[J]. J Natl Cancer Inst, 2009, 100 (16): 1134-1143.
10. YANG Y F, ZHAO W, ZHONG Y D, et al. Interferon therapy in chronic hepatitis B reduces progression to cirrhosis and hepatocellular carcinoma: a meta-analysis[J]. J Viral Hepat, 2009, 16 (4): 265-271.
11. XIE Y, ZHAO H, DAI W S, et al. HBV DNA level and antigen concentration in evaluating liver damage of patients with chronic hepatitis B[J]. Hepatobiliary Pancreat Dis Int, 2003, 2 (3): 418-422.
12. XU J, LIN Y, WANG Y P, et al. Hepatitis B virus DNA in patients with hepatitis B-relatedliver cirrhosis with or without hepatocellular carcinomas: a matched case-control study[J]. J Dig Dis, 2009, 10 (2): 138-144.
13. LIU T T, FANG Y, XIONG H, et al. A case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China [J]. World J Gastroenterol, 2008, 14 (19): 3059-3063.
14. SHAO J, WEI L, WANG H, et al. Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B[J]. World J Gastroenterol, 2007, 13 (14): 2104-2107.
15. HEO J H, HEO J, KWON D S, et al. Relationship between serum HBV DNA levels and liver histology in chronic hepatitis B[J]. Korean J Gastroenterol, 2003, 42 (3): 220-225.
16. CHOTIYAPUTTA W, LOK A S. Hepatitis B virus variants[J]. Nat Rev Gastroenterol Hepatol, 2009, 6 (8): 453-462.